SEC Filing Details

Document Details

Form
Filing Date
May 23, 2017
Document Date
May 19, 2017
Form Description

Statement of changes in beneficial ownership of securities

Filing Group
3,4,5
Company
Theravance Biopharma, Inc.
Issuer
Theravance Biopharma, Inc.